Residential sunlight exposure is associated with a decreased risk of prostate cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 89-90, Issue , 2004, Pages 549-552

  John, Esther M ^a   Dreon, Darlene M ^a   Koo, Jocelyn ^a   Schwartz, Gary G ^b  

^a NORTHERN CALIFORNIA CANCER CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Prostate cancer; Sunlight; Vitamin D

Indexed keywords

CALCIUM; FAT;

ADULT; AGED; CALCIUM INTAKE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DERMATOLOGY; DIETARY INTAKE; FAMILY HISTORY; FAT INTAKE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RESIDENTIAL HOME; RISK FACTOR; SOLAR RADIATION; SUN EXPOSURE; SUNLIGHT;

ADOLESCENT; AGED; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS; SUNLIGHT; UNITED STATES;

EID: 3042554083     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.03.067     Document Type: Conference Paper

References (16)

1. Hanchette C.L., Schwartz G.G. Geographic patterns of prostate cancer mortality: evidence for a protective effect of ultraviolet radiation. Cancer. 70:1992;2861-2869
2. 3. Cancer Res. 52:1992;515-520
3. Schwartz G.G., Wang M.-H., Zhang M., Sing R.K., Siegal G.P. 1α, 25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol. Biomarkers Prev. 6:1997;727-732
4. Lokeshwar B.L., Schwartz G.G., Selzer M.G., Burnstein K.L., Zhuang S.-H., Block N.L., Binderup L. Inhibition of prostate cancer metastasis in vivo: a comparison of 1, 25-dihydroxyvitamin D (calcitriol) and EB 1089. Cancer Epidemiol. Biomarkers Prev. 8:1999;241-248
5. Polek T.C., Weigel N.L. Vitamin D and prostate cancer. J. Androl. 23:2002;9-17. (review)
6. G.G. Schwartz, Prostate cancer and Vitamin D: from concept to clinic. A 10-year update, in: A.W. Norman, R. Bouillon, M. Thomasset (Eds.), Vitamin D Endocrine System, University of California Press, 2000, pp. 445-452.
7. Zhao X.-Y., Feldman D. The role of Vitamin D in prostate cancer. Steroids. 66:2001;291-300
8. Schwartz G.G., Hulka B.S. Is Vitamin D deficiency a risk factor for prostate cancer (hypothesis)? Anticancer Res. 10:1990;1307-1311
9. Chesney R.W., Rosen J.F., Hanstra A.J., Smith C., Mahaffey K., DeLuca H.F. Absence of seasonal variations in serum concentrations of 1, 25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. J. Clin. Endocrin. Metab. 53:1981;139-143
10. 3. Cancer Epidemiol. Biomarkers Prev. 7:1998;391-395
11. 2 for prostate cancer therapy. Clin. Cancer Res. 6:2000;901-908
12. 3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol. Biomarkers Prev. 9:2000;265-270
13. John E.M., Schwartz G.G., Dreon D.M., Koo J. Vitamin D and breast cancer risk: The NHANES Epidemiologic Follow-up Study, 1971-1975 to 1992. Cancer Epidemiol. Biomarkers Prev. 8:1999;309-406
14. Bodiwala D., Luscopmbe C.J., French M.E., Liu S., Saxby M.F., Jones P.W., et al. Susceptibility to prostate cancer: studies on interactions between UVR exposure and skin type. Carcinogenesis. 24:2003;711-717
15. Ahonen M.H., Tenkanen L., Teppo L., Hakama M., Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxvitamin D levels (Finland). Cancer Causes Control. 11:2000;847-852
16. Whitlatch L.W., Young M.V., Schwartz G.G., Flanagan J.N., Burnstein K.L., Lokeshwar B.L., et al. 25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J. Steroid Biochem. Mol. Biol. 81:2002;135-140